We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.23%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$31.7B
AUM Growth
+$592M
(+1.9%)
Cap. Flow
-$911M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,004
New
65
Increased
417
Reduced
345
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$334M |
| 2 |
TripAdvisor
TRIP
|
+$274M |
| 3 |
Enovis
ENOV
|
+$124M |
| 4 |
Booking.com
BKNG
|
+$70.2M |
| 5 |
SRCL
Stericycle Inc
SRCL
|
+$65.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fluor
FLR
|
+$293M |
| 2 |
Accenture
ACN
|
+$274M |
| 3 |
CVD
COVANCE INC.
CVD
|
+$203M |
| 4 |
Gilead Sciences
GILD
|
+$158M |
| 5 |
Fossil Group
FOSL
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.35% |
| 2 | Healthcare | 18.74% |
| 3 | Financials | 13.49% |
| 4 | Consumer Staples | 9.18% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Bristol-Myers Squibb
BMY
$124B
| $366M | 1.16% |
6,206,910
+5,919,161
| +2,057% | +$334M |
|
|
ANSS
27
DELISTED
Ansys
ANSS
| $332M | 1.05% |
4,048,107
-196,751
| -5% | -$15.6M |
|
|
CVD
28
DELISTED
COVANCE INC.
CVD
| $323M | 1.02% |
3,109,194
-2,163,808
| -41% | -$203M |
|
|
DISCK
29
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $290M | 0.91% |
8,598,194
+568,621
| +7% | +$19.4M |
|
|
NATI
30
DELISTED
National Instruments Corp
NATI
| $283M | 0.89% |
9,113,407
-433,594
| -5% | -$13.5M |
|
|
31
TripAdvisor
TRIP
$1.61B
| $262M | 0.83% |
+3,512,314
| New | +$274M |
|
32
Mastercard
MA
$470B
| $258M | 0.81% |
2,993,198
+32,644
| +1% | +$2.66M |
|
33
ExxonMobil
XOM
$640B
| $254M | 0.8% |
2,746,676
-169,074
| -6% | -$15.8M |
|
|
N
34
DELISTED
Netsuite Inc
N
| $242M | 0.76% |
2,220,738
+633,889
| +40% | +$64.7M |
|
35
Warner Bros
WBD
$64.8B
| $236M | 0.74% |
6,837,748
-369,222
| -5% | -$12.8M |
|
36
Wells Fargo
WFC
$262B
| $231M | 0.73% |
4,212,238
+174,138
| +4% | +$9.22M |
|
37
Best Buy
BBY
$18.4B
| $217M | 0.68% |
5,559,952
-244,949
| -4% | -$8.61M |
|
38
Microsoft
MSFT
$2.9T
| $213M | 0.67% |
4,575,330
-71,686
| -2% | -$3.36M |
|
39
Kinder Morgan
KMI
$72.3B
| $212M | 0.67% |
5,006,450
+456,310
| +10% | +$18M |
|
40
Berkshire Hathaway Class B
BRK.B
$1.06T
| $195M | 0.61% |
1,298,354
+38,340
| +3% | +$5.53M |
|
41
JPMorgan Chase
JPM
$926B
| $191M | 0.6% |
3,057,286
+63,917
| +2% | +$3.85M |
|
42
Canadian National Railway
CNI
$77.6B
| $175M | 0.55% |
2,544,786
+27,485
| +1% | +$1.88M |
|
43
Teva Pharmaceuticals
TEVA
$35.1B
| $166M | 0.52% |
2,889,321
+25,825
| +0.9% | +$1.44M |
|
44
Occidental Petroleum
OXY
$57.2B
| $161M | 0.51% |
2,005,607
-14,818
| -0.7% | -$1.23M |
|
|
45
Fossil Group
FOSL
$246M
| $158M | 0.5% |
1,424,207
-1,430,831
| -50% | -$149M |
|
46
Walt Disney
DIS
$166B
| $143M | 0.45% |
1,516,372
+26,829
| +2% | +$2.42M |
|
|
47
Enovis
ENOV
$1.53B
| $143M | 0.45% |
1,607,436
+1,366,491
| +567% | +$124M |
|
48
Lowe's Companies
LOW
$115B
| $137M | 0.43% |
1,997,716
+53,063
| +3% | +$3.18M |
|
49
Merck
MRK
$315B
| $130M | 0.41% |
2,401,802
-185,949
| -7% | -$10.4M |
|
|
50
Accenture
ACN
$85.7B
| $129M | 0.41% |
1,448,940
-3,301,863
| -70% | -$274M |
|
Similar funds
QCM
Brown Advisory's Q4 2014 Portfolio in Review
As of Q4 2014, Brown Advisory held 1,004 positions worth $31.7B, up 1.9% from $31.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Brown Advisory's Q4 2014 filing shows 65 new, 417 increased, 345 reduced and 79 closed positions. Its largest new stake was TripAdvisor: 3,512,314 shares worth $262M. The largest sale was Fluor, an estimated $293M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2014 buy was TripAdvisor: 3,512,314 shares worth $262M.
- Brown Advisory added most to Bristol-Myers Squibb in Q4 2014, an estimated $334M increase.
- Brown Advisory's biggest Q4 2014 reduction was Fluor, cutting an estimated $293M.
- Brown Advisory fully exited Guess Inc in Q4 2014, selling an estimated $27.1M.
- Brown Advisory's ten largest holdings make up 28% of its $31.7B portfolio in Q4 2014.
- Brown Advisory opened 65 new positions and closed 79 in Q4 2014.
- Brown Advisory's portfolio value rose 1.9% quarter-over-quarter to $31.7B.
Based on Brown Advisory's 13F filing for Q4 2014, filed 9 Feb 2015.